Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / QLGN - Qualigen stock rises on acquiring majority stake in Israeli diagnostics company NanoSynex

QLGN - Qualigen stock rises on acquiring majority stake in Israeli diagnostics company NanoSynex

Qualigen Therapeutics Inc.
Qualigen Therapeutics (NASDAQ:QLGN) stock rose June 2 after the company said it completed the acquisition of a majority stake in Israeli diagnostics company NanoSynex. Qualigen said NanoSynex's technology is an Antimicrobial Susceptibility Testing (AST) platform that aims to provide accurate and personalized test for bacterial infections, with the goal of matching the correct antibiotics to treat a patient's particular infection. Qualigen noted that the acquisition of the controlling stake was mainly done by a stock-for-stock acquisition with a controlling shareholder of NanoSynex.

For further details see:

Qualigen stock rises on acquiring majority stake in Israeli diagnostics company NanoSynex
Stock Information
Company Name: Qualigen Therapeutics Inc.
Stock Symbol: QLGN
Market: NASDAQ
Website: qualigeninc.com
Menu
QLGN QLGN Quote QLGN Short QLGN News QLGN Articles QLGN Message Board
Get QLGN Alerts

News, Short Squeeze, Breakout and More Instantly...